ArticleOPEN ACCESS

Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel?

Cancer
DOI: 10.1002/cncr.30532
19Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Stahl, M., & Zeidan, A. M. (2017, March 15). Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel? Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/cncr.30532

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free